Epidemiology and Treatment of HR+/HER2- Breast Cancer in England
Clinical trial NCT07498413 · COMPLETED
Trial details
- NCT number
- NCT07498413
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-06-08
- Primary completion
- 2025-07-18
- Enrollment
- 218677
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.